SLV313 (1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-4- [5-(4-fluoro-phenyl)- pyridin-3-ylmethyl]-piperazine monohydrochloride): A novel dopamine D 2 receptor antagonist and 5-HT1A receptor agonist potential antipsychotic drug
Andrew C. McCreary*, Jeffrey C. Glennon, Charles R. Ashby, Herbert Y. Meltzer, Zhu Li, Jan Hendrik Reinders, Mayke B. Hesselink, Stephen K. Long, Arnoud H. Herremans, Herman Van Stuivenberg, Rolf W. Feenstra, Chris G. Kruse
Dive into the research topics of 'SLV313 (1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-4- [5-(4-fluoro-phenyl)- pyridin-3-ylmethyl]-piperazine monohydrochloride): A novel dopamine D 2 receptor antagonist and 5-HT1A receptor agonist potential antipsychotic drug'. Together they form a unique fingerprint.